Glass House Brands (GLAS) Convertible Debt (2020)
Glass House Brands' (GLAS) quarterly Convertible Debt came in at $7.4 million in Q4 2020.
Glass House Brands (GLAS) Convertible Debt (2020) Analysis & Trends
Glass House Brands (GLAS) has 1 years of Convertible Debt data on file, last reported at $7.4 million in Q4 2020.
- On a quarterly basis, Convertible Debt changed N/A year-over-year to $7.4 million in Q4 2020; TTM through Dec 2020 was $7.4 million, a N/A change from a year earlier, with the FY2020 full-year figure at $7.4 million, changed N/A from the prior year.
- Convertible Debt for Q4 2020 stood at $7.4 million.
- Over the last five years, Convertible Debt for GLAS reached as high as $7.4 million in Q4 2020 and fell as low as $7.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 7.37 Mn |